TLE3: A Potential Drug Target or Biomarker for various Diseases

Target Name: LINC02074

NCBI ID: G102723567

LINC02074

Other Name(s): LOC102723567 variant X5 | Uncharacterized LOC102723567, transcript variant X5 | long intergenic non-protein coding RNA 2074

TLE3: A Potential Drug Target or Biomarker for various Diseases

LINC02074 (LOC102723567) is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer. The gene is located on chromosome 18 and encodes a protein known as TLE3 (Tumor Suppressor Protein 3).

TLE3 is a protein that is expressed in various tissues throughout the body, including the skin, hair, and nails. It is known for its ability to suppress the growth and spread of cancer cells. In addition, TLE3 has also been shown to play a role in the regulation of cell death and has been linked to the development of certain diseases, including cancer.

Research has suggested that TLE3 may be a useful drug target or biomarker for the treatment of various diseases, including cancer. One reason for this is that TLE3 has been shown to be expressed in various types of cancer, including breast, ovarian, and prostate cancer. Additionally, studies have shown that TLE3 has been able to inhibit the growth and spread of cancer cells in cell culture and animal models.

In addition to its potential as a drug target or biomarker, TLE3 has also been studied for its potential uses in other areas. For example, TLE3 has been shown to be involved in the regulation of pain perception and has been linked to the development of chronic pain. Additionally, TLE3 has also been studied for its potential uses in skin diseases, including dermatitis and psoriasis.

Overall, LINC02074 (LOC102723567) is a gene that has the potential to be a drug target or biomarker for the treatment of various diseases, including cancer. Further research is needed to fully understand the role of TLE3 in these diseases and to develop safe and effective treatments.

Protein Name: Long Intergenic Non-protein Coding RNA 2074

The "LINC02074 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC02074 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets